DICE THERAPEUTICS INC's ticker is and the CUSIP is 23345J104. A total of 78 filers reported holding DICE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $4,814,539 | -85.5% | 103,629 | -91.1% | 0.00% | -86.4% |
| Q1 2023 | $33,216,751 | -2.6% | 1,159,664 | +6.1% | 0.02% | -8.3% |
| Q4 2022 | $34,104,032 | +2.7% | 1,093,418 | -66.6% | 0.02% | -4.0% |
| Q3 2022 | $33,208,175 | +25.2% | 3,271,296 | +91.4% | 0.02% | +38.9% |
| Q2 2022 | $26,528,000 | -23.3% | 1,709,320 | -5.4% | 0.02% | +5.9% |
| Q1 2022 | $34,567,000 | -24.2% | 1,806,918 | -1.8% | 0.02% | -10.5% |
| Q4 2021 | $45,614,000 | -22.2% | 1,839,229 | -1.3% | 0.02% | -26.9% |
| Q3 2021 | $58,627,000 | – | 1,864,207 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|